3 days popular7 days popular1 month popular3 months popular

Stem Cells USA And Regenerative Medicine Congress, 20-21 September 2012, Boston

The stem cell and industry is facing a serious funding problem. Just as the first therapies are reaching commercialization, biotechs in phase 2 and 3 are struggling to raise the funds needed to finish their studies.

Over 300 biotechs, pharmas, investors, and suppliers will be meeting in Boston on September 20-21 at the and 2012.

Key speakers include Todd McAllister, CEO of Cytograft Tissue Engineering, Gary Rabin, CEO of , , CEO of Organogenesis, and , Chairman and CEO of Athersys.

This event is designed to help biotechs learn the strategies necessary to raise capital and sustain clinical development through phase 3 and help pharmas identify the most lucrative companies and technologies currently being developed in the space. Furthermore, this event is co-located with the first-ever World Cord Blood Congress. Participants will learn:

  • How to raise and sustain funding through phase I, II, and III trials
  • How to source the newest and most exciting stem cell technology
  • How to take a product from inception to commercialization
  • How to ensure reimbursement for novel regenerative therapies

To register or learn more visit http://www.terrapinn.com/stemcellsusa

CONTACT:
Caroline Hornby, Marketing Manager
Terrapinn
[email protected]
+1 646 619 1792

Source

About Terrapinn:
Terrapinn is a business media company. Our products are trade exhibitions, conferences, training solutions and electronic and print publications. More information and a schedule of our events can be found at http://www.terrapinn.com.